Edis Kahraman

Dr. Edis Kahraman


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2026 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Open access
EKEdis Kahraman
Edis Kahraman
NKNadiye Köroğlu
Nadiye Köroğlu
TATurgut Aydın
Turgut Aydın
MYMehmet Aytaç Yüksel
Mehmet Aytaç Yüksel
Purpose: To evaluate whether the number of sutures used during transvaginal cervical cerclage influences obstetric and neonatal outcomes when surgical technique, suture material, and perioperative management are standardized. Methods: This retrospective cohort study included 125 women who underwent transvaginal cervical cerclage using identical monofilament suture material. Cerclage was performed with either a single suture ( n = 23) or a double suture ( n = 102) in this non-randomized observational cohort. The primary outcome was term delivery (≥ 37 weeks’ gestation). Secondary outcomes included gestational age at delivery and selected neonatal outcomes. To address non-random allocation and baseline group imbalance, propensity scores were estimated using pre-treatment maternal, obstetric, and clinical severity variables. Stabilized inverse probability of treatment weighting (IPTW) with truncation was applied, and doubly robust outcome models were used to estimate adjusted associations. Neonatal outcomes were analyzed at the pregnancy level to account for clustering in twin gestations. Results: Women receiving double-suture cerclage presented at earlier gestational ages and with greater markers of cervical severity at baseline; however, after IPTW and doubly robust adjustment accounting for these baseline differences, no statistically significant difference in term delivery was observed. Secondary obstetric outcomes, including gestational age at delivery, were also comparable between groups after adjustment. Pregnancy-level neonatal outcomes, including NICU admission and neonatal mortality, did not differ meaningfully by suture number. Sensitivity analysis restricted to singleton pregnancies and stratified by cerclage indication yielded consistent results. Conclusion: After accounting for baseline cervical severity and clinical indication, single- and double-suture transvaginal cerclage was associated with comparable obstetric and neonatal outcomes under standardized surgical conditions. These findings suggest that cervical status at the time of cerclage placement, rather than the number of sutures applied, is the primary determinant of outcome.

1 January 2026 in Case Reports in Perinatal Medicine
Verified
Journal Article
Open access
AÇAyberk Çakır
Ayberk Çakır
EKEdis Kahraman
Edis Kahraman
DGDeniz Gedik
Deniz Gedik
NANefise Bengü Akgün
Nefise Bengü Akgün
MYMehmet Aytaç Yüksel
Mehmet Aytaç Yüksel
Objectives: Premature constriction of the fetal ductus arteriosus is a clinically relevant cause of fetal cardiac compromise. Maternal exposure to prostaglandin-inhibiting analgesics is a recognized trigger. We describe two pregnancies complicated by fetal ductus arteriosus constriction temporally associated with maternal analgesic use. Case presentation: In the first case, ductal constriction occurred after a seven-day course of indomethacin initiated at 28 weeks’ gestation for polyhydramnios. Although initial improvement followed drug discontinuation, recurrent constriction with right ventricular dilation, severe tricuspid regurgitation, ductus venosus A-wave reversal, and a non-reactive fetal heart rate tracing indicated progressive hemodynamic compromise, prompting preterm delivery at 31+6 weeks. Postnatal echocardiography showed normalization of right ventricular function. In the second case, ductal constriction with right ventricular dilation and tricuspid regurgitation was detected at 38+5 weeks after frequent third-trimester use of a paracetamol-containing analgesic. Delivery at 39 weeks was performed primarily for prior uterine surgery, and postnatal evaluation confirmed normal pulmonary pressures and right ventricular function. Conclusions: Maternal exposure to prostaglandin-inhibiting analgesics should be considered in cases of fetal ductus arteriosus constriction. Careful medication history and targeted fetal echocardiography are essential for timely diagnosis and appropriate perinatal management.

15 July 2026 in Human Reproduction
Verified
Journal Article
Open access
TATurgut Aydin
Turgut Aydin
NKNadiye köroğlu
Nadiye köroğlu
EKEdis Kahraman
Edis Kahraman
NANazli Albayrak
Nazli Albayrak
EKElif Kose
Elif Kose
STUDY QUESTION: Does progesterone-based embryo transfer timing achieve live birth rates comparable to LH-surge-based timing in true natural cycle frozen embryo transfer (NC-FET)? SUMMARY ANSWER: Progesterone-based embryo transfer timing was associated with live birth rates comparable to those achieved with LH surge-based timing in true NC-FET, with no evidence of an independent association between ovulation timing strategy and live birth after adjustment for potential confounders. WHAT IS KNOWN ALREADY: In true NC-FET, embryo transfer timing is commonly scheduled according to the LH surge. However, identification of the LH surge may be challenging. Serum progesterone rise may reflect ovulation timing, yet its use as an alternative approach for scheduling embryo transfer in NC-FET cycles remains insufficiently investigated. STUDY DESIGN, SIZE, DURATION: This prospective cohort study included 490 true NC-FET cycles performed at a single tertiary IVF center between 2022 and 2025. Cycles were analyzed according to the ovulation timing strategy used for embryo transfer scheduling: progesterone-based timing (n = 286) or LH surge-based timing (n = 204). PARTICIPANTS/MATERIALS, SETTING, METHODS: Ovulation was monitored using serial ultrasound and serum hormone measurements. Embryo transfer timing was scheduled according to either detection of the LH surge or the rise in serum progesterone concentrations. The primary outcome was live birth. Adjusted relative risks were estimated using modified Poisson regression with robust standard errors, adjusting for infertility duration and etiology, endometrial thickness at transfer, embryo quality, and number of embryos transferred. Adjusted absolute risk differences were calculated using marginal standardization. An exploratory threshold-based assessment was performed on the risk-difference scale. MAIN RESULTS AND THE ROLE OF CHANCE: Live birth occurred in 162 of 286 progesterone-timed cycles (56.6%) and 106 of 204 LH-timed cycles (52.0%) (unadjusted RR 1.09, 95% CI 0.93–1.28). After adjustment, ovulation timing strategy showed no evidence of an independent association with live birth (adjusted RR 1.09, 95% CI 0.93–1.30; P = 0.264). The adjusted absolute risk difference was +4.9% (95% CI −3.8% to +13.6%). Clinical pregnancy, hCG positivity, and miscarriage rates were also comparable between groups. In exploratory analyses, follicle size measured 1 day before ovulation was positively correlated with progesterone levels on the embryo transfer day (Spearman r = 0.36, P < 0.001), and embryo-transfer-day progesterone levels were positively correlated with estradiol levels measured 1 day before ovulation (Spearman r = 0.29, P < 0.001). LIMITATIONS, REASONS FOR CAUTION: The observational design may introduce residual confounding despite statistical adjustment. The timing strategy was not randomized and reflected an evolving institutional protocol. In addition, the progesterone thresholds were derived and applied within a single-center assay environment, which may limit generalizability to other clinical settings and laboratory platforms. WIDER IMPLICATIONS OF THE FINDINGS: Progesterone-based timing may represent a feasible alternative to LH-based scheduling in true NC-FET, although confirmation in adequately powered multicenter studies is required. STUDY FUNDING/COMPETING INTEREST(S): No external funding was received for this study. The authors declare no competing interests. TRIAL REGISTRATION NUMBER: N/A.

28 October 2025 in Natural Sciences
Verified
Journal Article
Open access
AÇAyberk Çakır
Ayberk Çakır
FKFulya Kayıkçıoğlu
Fulya Kayıkçıoğlu
GÖGürkan Özbey
Gürkan Özbey
EKEdis Kahraman
Edis Kahraman
This study was performed to assess the efficacy, safety, and prognostic factors of treatment protocols in patients with high‐risk gestational trophoblastic neoplasia (GTN). Data of 64 high‐risk GTN patients treated at our clinic between January 1993 and December 2020 were retrospectively analyzed. Patients were classified according to the FIGO staging and World Health Organization (WHO) scoring system, and demographic characteristics, treatment protocols (etoposide, methotrexate, actinomycin‐D, cyclophosphamide, vincristine [EMACO]; methotrexate, actinomycin‐D, cyclophosphamide [MAC]; etoposide, methotrexate, actinomycin‐D, etoposide, cisplatin [EMAEP]), complications, and survival outcomes were evaluated. The presence of metastatic disease, beta‐human chorionic gonadotropin (β‐hCG) levels, and treatment responses were analyzed in detail. The median age of the patients was 31.5 years (19–57), and 65.6% had metastatic disease. The most commonly used chemotherapy protocol was EMACO (75% of patients). Primary chemotherapy failure was seen in 42.1%, and the median number of cycles given until β‐hCG reset was 3 (1–9). Complete remission was achieved in 90.6% of the patients, whereas 9.4% died. The most common complications were neutropenia (24.3%), elevated liver function tests (17.6%), and anemia (17.6%). The presence of brain metastasis and a high WHO score (11–15) were significantly associated with mortality ( p < 0.05). The EMACO protocol is a good option for the treatment of high‐risk GTN; however, the prognosis is worse, particularly in patients with brain metastases and a high WHO score. Improving the diagnosis and choosing the appropriate treatment protocol are crucial for the management of this disease. Summary: It provides real‐world data on treatment outcomes from a substantial cohort of high‐risk GTN patients treated at a single institution. It offers detailed analysis of chemotherapy‐related complications across different regimens, information that is often underreported in the literature. It identifies specific patient subgroups who may benefit from alternative treatment approaches, potentially guiding more tailored management strategies. It contributes to the ongoing discussion about the limitations of current FIGO scoring and staging systems.

2 September 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
Elif Ganime AygünElif Ganime Aygün
Elif Ganime Aygün
EKEdis Kahraman
Edis Kahraman
Background/Objectives: The role of luteal phase support (LPS) in frozen–thawed embryo transfer (FET) cycles has garnered increasing interest, particularly regarding its influence on uterine perfusion and pregnancy outcomes. This study aimed to investigate the effect of different oral LPS regimens on first-trimester uterine artery Doppler indices and their association with early pregnancy outcomes in naturally conceived and FET pregnancies. Methods: This retrospective cohort study included 289 singleton pregnancies comprising spontaneous conceptions, FET cycles supported with oral micronised progesterone, and FET cycles supported with oral dydrogesterone. The uterine artery pulsatility index (PI) was measured via Doppler ultrasound during the first trimester. Group comparisons were performed using non-parametric tests. Multivariable regression analyses were used to assess independent predictors of PI and associations with gestational diabetes and low birth weight. Results: Uterine artery PI values differed significantly among the groups (p < 0.001). The lowest PI was observed in the dydrogesterone group, followed by the naturally conceived and micronised progesterone groups. A higher maternal body mass index (BMI) was independently associated with lower PI (p = 0.009), while maternal age showed no significant effect. No significant associations were found between PI or maternal characteristics and adverse outcomes such as gestational diabetes or low birth weight. Conclusions: Dydrogesterone was associated with more favorable uterine artery Doppler indices in early pregnancy, suggesting improved uteroplacental adaptation in FET cycles. These findings support further prospective research to determine the clinical impact of LPS regimens on placental development and perinatal health.

15 October 2025 in Clinical and Experimental Obstetrics & Gynecology
Verified
Journal Article
Open access
EKEdis Kahraman
Edis Kahraman
Elif Ganime AygünElif Ganime Aygün
Elif Ganime Aygün
Background: Obesity significantly influences female reproductive health; however, its specific impact on hormonal predictors of ovarian response remains uncertain. The follicle-stimulating hormone (FSH)/ anti-Mullerian hormone (AMH) ratio has recently gained attention as a potential marker of ovarian reserve and response to controlled ovarian stimulation. This study aimed to assess the association between the FSH/AMH ratio and oocyte count and to determine whether body mass index (BMI) modifies this relationship. Methods: In this retrospective study, 185 women undergoing ovarian stimulation were reviewed, and 92 met predefined clinical and hormonal inclusion criteria. Baseline FSH, luteinizing hormone (LH), AMH, BMI, and oocyte counts were recorded, and the FSH/AMH ratio was calculated. Associations were assessed using Spearman correlation, Kruskal-Wallis tests, and linear regression analysis. Results: AMH levels showed a strong positive correlation with oocyte count, while the FSH/AMH ratio demonstrated a strong negative correlation. FSH exhibited a weak negative correlation, and no significant association was observed between BMI and hormonal markers. Neither oocyte count nor the FSH/AMH ratio differed significantly across BMI categories. Linear regression analysis confirmed that the FSH/AMH ratio was an independent predictor of oocyte yield (p < 0.001), whereas BMI and its interaction with the ratio were not statistically significant. Conclusions: The FSH/AMH ratio is a reliable and BMI-independent predictor of ovarian response. These findings support its clinical utility in fertility assessment and treatment planning, particularly when standard markers are inconclusive.